235 related articles for article (PubMed ID: 17381371)
21. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
22. Strategic opportunities for effective optimal prescribing and medication management.
Sketris IS; Langille Ingram EM; Lummis HL
Can J Clin Pharmacol; 2009; 16(1):e103-25. PubMed ID: 19182305
[TBL] [Abstract][Full Text] [Related]
23. Sudden cardiac arrest prevention pathways and tools.
Fonarow GC; Albert NM; Cannom D; Lewis WR; Shea J; Walsh MN
Crit Pathw Cardiol; 2009 Jun; 8(2):79-87. PubMed ID: 19491574
[TBL] [Abstract][Full Text] [Related]
24. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
25. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
26. Tailoring consumer resources to enhance self-care in chronic heart failure.
Driscoll A; Davidson P; Clark R; Huang N; Aho Z
Aust Crit Care; 2009 Aug; 22(3):133-40. PubMed ID: 19581110
[TBL] [Abstract][Full Text] [Related]
27. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
Forman DE; Cannon CP; Hernandez AF; Liang L; Yancy C; Fonarow GC;
Am Heart J; 2009 Jun; 157(6):1010-7. PubMed ID: 19464411
[TBL] [Abstract][Full Text] [Related]
28. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
Castelino RL; Bajorek BV; Chen TF
Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
[TBL] [Abstract][Full Text] [Related]
29. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
30. Systems ambiguity and guideline compliance: a qualitative study of how intensive care units follow evidence-based guidelines to reduce healthcare-associated infections.
Gurses AP; Seidl KL; Vaidya V; Bochicchio G; Harris AD; Hebden J; Xiao Y
Qual Saf Health Care; 2008 Oct; 17(5):351-9. PubMed ID: 18842974
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based strategies for the optimization of pharmacotherapy in older people.
Topinková E; Baeyens JP; Michel JP; Lang PO
Drugs Aging; 2012 Jun; 29(6):477-94. PubMed ID: 22642782
[TBL] [Abstract][Full Text] [Related]
32. Boost outcomes--add a clinical pharmacist to the team.
Clin Resour Manag; 2001 Jan; 2(1):6-10, 1. PubMed ID: 11215356
[TBL] [Abstract][Full Text] [Related]
33. The heart failure and sodium restriction controversy: challenging conventional practice.
Beich KR; Yancy C
Nutr Clin Pract; 2008; 23(5):477-86. PubMed ID: 18849552
[TBL] [Abstract][Full Text] [Related]
34. Performance measures have a major effect on cardiovascular outcomes: a review.
Mehta RH; Peterson ED; Califf RM
Am J Med; 2007 May; 120(5):398-402. PubMed ID: 17466646
[TBL] [Abstract][Full Text] [Related]
35. Retiree health care: a new model for improving health and reducing costs.
Erwin WG; Angaran DM
Empl Benefits J; 1997 Jun; 22(2):2-4. PubMed ID: 10168419
[TBL] [Abstract][Full Text] [Related]
36. [The effect of health care reform in Germany on the pharmacist's role in pharmacotherapy].
Ginzelová P; Kugler KH; Solich J
Ceska Slov Farm; 1999 Sep; 48(5):207-13. PubMed ID: 10566240
[TBL] [Abstract][Full Text] [Related]
37. Role and Value of Clinical Pharmacy in Heart Failure Management.
Stough WG; Patterson JH
Clin Pharmacol Ther; 2017 Aug; 102(2):209-212. PubMed ID: 28295269
[TBL] [Abstract][Full Text] [Related]
38. Beta-blocker therapy in heart failure in the elderly.
Fu M
Int J Cardiol; 2008 Apr; 125(2):149-53. PubMed ID: 18023898
[TBL] [Abstract][Full Text] [Related]
39. Polypharmacy in the elderly: maximizing benefit, minimizing harm.
Ballentine NH
Crit Care Nurs Q; 2008; 31(1):40-5. PubMed ID: 18316935
[TBL] [Abstract][Full Text] [Related]
40. Treatment Considerations and the Role of the Clinical Pharmacist Throughout Transitions of Care for Patients With Acute Heart Failure.
McNeely EB
J Pharm Pract; 2017 Aug; 30(4):441-450. PubMed ID: 27129914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
